chAIron blends AI with human expertise to revolutionize R&D. Our goal is to identify new indications innovatively and unlock the full potential of companies’ assets. We believe in continuously pushing the boundaries of technology and individuals to make a positive impact on people’s lives.

Products, services, technology
  • Indication Discovery: Our AI-driven analysis unlocks new indications for novel and existing drugs.
  • Maximizing Asset Value: We assess molecules with a data-driven approach, guiding strategic decisions on programs' development based on scientific viability, technical feasibility, and market impact.
Cooperation possibilities

We offer tailored strategic decision-making analysis and advice for R&D leaders, business development teams, and industry investors. Our expertise includes roadmaps for clinical and corporate strategies to minimise risk in the research-to-market journey and guiding decisions in partnerships and M&A.

Some insights
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business

You may also be interested in